Literature DB >> 20237420

NSP 5a3a's link to nuclear-cyto proteins B23 and hnRNP-L between normal and aberrant breast cell lines.

Luca D'Agostino1, Valentina Caracciolo, Antonio Giordano.   

Abstract

NSP 5a3a had been identified along with three other distinct though similar isoforms corresponding to locus HCMOGT-1 on chromosome 17p11.2. ( 1) Secondary structure analysis of the NSP isoforms revealed similarity to Spectrin and Spectrin like proteins containing coiled coil domains. ( 1) These proteins have been implicated and found to be involved in a plethora of cellular activities ranging from intracellular trafficking, cellular and subcellular integrity ( 2, 3) to being involved in protein-protein interactions with other structural proteins as well as involved in protein complex stabilization and scaffolding thus facilitating homo or hetero dimerization of protein complexes. ( 4) The NSP 5a3a isoform had been identified to be highly expressed in-vitro in particular cancer cell lines while very low to null in normal body tissues. ( 1) Subsequent investigation of this isoform revealed its novel interaction with B23 ( 5) , a known nucleolar protein involved in ribosome biogenesis, rRNA transcription, mitosis, cell growth control, and apoptosis. ( 6) We have since then, further elucidated its potential involvement in cellular processes such as ribosome biogenesis and rRNA processing by confirming and establishing NSP 5a3a's novel interaction with B23 and ribonuclear protein hnRNP-L, respectively thus possibly implicating NSP 5a3a in cellular processes such as ribosome biogenesis and rRNA transcription . Finally, an intriguing differential cooperation between these proteins has been observed in both normal and cancer breast cell models and additionally through siRNa silencing, we have found hnRNP-L as a potential novel regulator of NSP 5a3a.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20237420     DOI: 10.4161/cc.9.6.10991

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  10 in total

1.  Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.

Authors:  Kenneth J Dery; Craig Silver; Lu Yang; John E Shively
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

2.  NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling.

Authors:  Mikael S Lindström
Journal:  Biochem Res Int       Date:  2010-10-05

3.  NSP 5a3a: a potential novel cancer target in head and neck carcinoma.

Authors:  Luca D'agostino; Antonio Giordano
Journal:  Oncotarget       Date:  2010-10

4.  Could NSP5a3a be a target for head and neck cancer?

Authors:  Martyn K White; Kamel Khalili
Journal:  Oncotarget       Date:  2010-10

5.  A novel dual signaling axis for NSP 5a3a induced apoptosis in head and neck carcinoma.

Authors:  Luca D'Agostino; Antonio Giordano
Journal:  Oncotarget       Date:  2011-12

6.  Interplay between miR-574-3p and hnRNP L regulates VEGFA mRNA translation and tumorigenesis.

Authors:  Peng Yao; Jiangbin Wu; Daniel Lindner; Paul L Fox
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

7.  HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways.

Authors:  Daojun Lv; Huayan Wu; Rongwei Xing; Fangpeng Shu; Bin Lei; Chengyong Lei; Xumin Zhou; Bo Wan; Yu Yang; Liren Zhong; Xiangming Mao; Yaguang Zou
Journal:  Oncotarget       Date:  2017-02-21

8.  HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis.

Authors:  Xumin Zhou; Qi Li; Jincan He; Liren Zhong; Fangpeng Shu; Rongwei Xing; Daojun Lv; Bin Lei; Bo Wan; Yu Yang; Huayan Wu; Xiangming Mao; Yaguang Zou
Journal:  Oncotarget       Date:  2017-03-21

9.  Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.

Authors:  Lingfeng Xu; Jiaoxiang Shen; Jun Jia; Rong Jia
Journal:  Biomed Res Int       Date:  2019-11-13       Impact factor: 3.411

10.  Splicing Factor Transcript Abundance in Saliva as a Diagnostic Tool for Breast Cancer.

Authors:  Mercedes Bentata; Guy Morgenstern; Yuval Nevo; Gillian Kay; Avital Granit Mizrahi; Mark Temper; Ofra Maimon; Liza Monas; Reham Basheer; Asa Ben-Hur; Tamar Peretz; Maayan Salton
Journal:  Genes (Basel)       Date:  2020-08-03       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.